Assessment of the Safety, Efficacy, and Benefit of Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Heart Failure With Reduced Ejection Fraction (HFrEF) at High Risk for Cardiovascular Events
评估恩格列净在伴有射血分数降低的心力衰竭（HFrEF）且心血管事件高风险的2型糖尿病（T2DM）患者中的安全性、有效性和获益
期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.33070
Towiargi, Ruba; Fetyani, Lama; Aljahdali, Naila; Alnofeie, Adnan; Alnoamy, Yahya; Ghandorah, Reham; Abduljawad, Abrar; Alharbi, Njood; Alghanmi, Alanoud; AlButi, Hala
